Benzinga | May 5, 2021 06:06AM EDT

United Therapeutics Q1 Adj. EPS $3.49 Beats $2.94 Estimate, Sales $379.10M Beat $368.95M Estimate

United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $3.49 per share which beat the analyst consensus estimate of $2.94 by 18.71 percent. This is a 3.32 percent decrease over earnings of $3.61 per share from the same period last year. The company reported quarterly sales of $379.10 million which beat the analyst consensus estimate of $368.95 million by 2.75 percent. This is a 6.40 percent increase over sales of $356.30 million the same period last year.